Mafalda Videira

2.3k total citations
46 papers, 1.7k citations indexed

About

Mafalda Videira is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mafalda Videira has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Mafalda Videira's work include RNA Interference and Gene Delivery (9 papers), Nanoparticle-Based Drug Delivery (8 papers) and Inhalation and Respiratory Drug Delivery (8 papers). Mafalda Videira is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Nanoparticle-Based Drug Delivery (8 papers) and Inhalation and Respiratory Drug Delivery (8 papers). Mafalda Videira collaborates with scholars based in Portugal, Spain and Romania. Mafalda Videira's co-authors include António J. Almeida, Helena F. Florindo, María Alexandra Brito, Diana Rafael, Fernanda Andrade, Domingos Ferreira, Bruno Sarmento, Joana M. Silva, Rogério Gaspar and Véronique Préat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Drug Delivery Reviews.

In The Last Decade

Mafalda Videira

46 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mafalda Videira Portugal 23 736 408 388 342 336 46 1.7k
Sushilkumar Patil India 16 712 1.0× 183 0.4× 286 0.7× 495 1.4× 234 0.7× 19 1.6k
Imran Vhora India 21 877 1.2× 148 0.4× 325 0.8× 617 1.8× 231 0.7× 25 1.8k
Adam W. G. Alani United States 26 716 1.0× 144 0.4× 266 0.7× 790 2.3× 537 1.6× 53 2.3k
Hanh Thuy Nguyen South Korea 31 818 1.1× 200 0.5× 278 0.7× 864 2.5× 267 0.8× 68 2.5k
Sumio Chono Japan 23 839 1.1× 548 1.3× 96 0.2× 400 1.2× 447 1.3× 73 1.9k
Dipesh Baradia India 13 650 0.9× 151 0.4× 243 0.6× 437 1.3× 155 0.5× 16 1.4k
Jiasheng Tu China 30 988 1.3× 266 0.7× 289 0.7× 971 2.8× 539 1.6× 97 2.9k
Mengchi Sun China 28 843 1.1× 231 0.6× 334 0.9× 783 2.3× 246 0.7× 82 2.3k
Ping Tan China 23 652 0.9× 371 0.9× 402 1.0× 421 1.2× 66 0.2× 88 2.2k
Raquel Petrilli Brazil 20 782 1.1× 114 0.3× 193 0.5× 684 2.0× 378 1.1× 45 1.7k

Countries citing papers authored by Mafalda Videira

Since Specialization
Citations

This map shows the geographic impact of Mafalda Videira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mafalda Videira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mafalda Videira more than expected).

Fields of papers citing papers by Mafalda Videira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mafalda Videira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mafalda Videira. The network helps show where Mafalda Videira may publish in the future.

Co-authorship network of co-authors of Mafalda Videira

This figure shows the co-authorship network connecting the top 25 collaborators of Mafalda Videira. A scholar is included among the top collaborators of Mafalda Videira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mafalda Videira. Mafalda Videira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Videira, Mafalda, et al.. (2025). Dual Approaches in Oncology: The Promise of siRNA and Chemotherapy Combinations in Cancer Therapies. SHILAP Revista de lepidopterología. 5(1). 2–2. 10 indexed citations
2.
Lima, Beatriz Silva, Paulo André Teixeira de Moraes Gomes, Maíra Galdino da Rocha Pitta, et al.. (2024). Thiazolyl-isatin derivatives: Synthesis, in silico studies, in vitro biological profile against breast cancer cells, mRNA expression, P-gp modulation, and interactions of Akt2 and VIM proteins. Chemico-Biological Interactions. 394. 110954–110954. 4 indexed citations
3.
Zhang, Guanghong, et al.. (2023). Hypericum foliosum Quality Botanical and Chemical Markers and In Vitro Antioxidant and Anticancer Activities. Plants. 12(5). 1087–1087. 2 indexed citations
4.
5.
Videira, Mafalda, Jordi Llop, Unai Cossío, et al.. (2020). Pulmonary Administration: Strengthening the Value of Therapeutic Proximity. Frontiers in Medicine. 7. 50–50. 14 indexed citations
6.
Rafael, Diana, Fernanda Andrade, Sara Montero‐Herradón, et al.. (2018). Rational Design of a siRNA Delivery System: ALOX5 and Cancer Stem Cells as Therapeutic Targets. SHILAP Revista de lepidopterología. 1(2). 86–105. 5 indexed citations
7.
Videira, Mafalda, et al.. (2017). Brain metastasization of breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1868(1). 132–147. 69 indexed citations
8.
Mateus, Rita, et al.. (2015). Implications of Akt2/Twist crosstalk on breast cancer metastatic outcome. Drug Discovery Today. 20(9). 1152–1158. 31 indexed citations
9.
Agostinho, Ana, Rita Mateus, Carolina Pereira, et al.. (2015). Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines. Current Cancer Drug Targets. 14(9). 832–849. 12 indexed citations
10.
Videira, Mafalda, et al.. (2014). Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1846(2). 312–325. 72 indexed citations
11.
Silva, Joana M., Eva Zupančič, Gaëlle Vandermeulen, et al.. (2014). In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model. Journal of Controlled Release. 198. 91–103. 113 indexed citations
12.
Andrade, Fernanda, Diana Rafael, Mafalda Videira, et al.. (2013). Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Advanced Drug Delivery Reviews. 65(13-14). 1816–1827. 176 indexed citations
13.
Videira, Mafalda, Alexandra Arranja, Diana Rafael, & Rogério Gaspar. (2013). Preclinical development of siRNA therapeutics: Towards the match between fundamental science and engineered systems. Nanomedicine Nanotechnology Biology and Medicine. 10(4). 689–702. 45 indexed citations
14.
Videira, Mafalda, Alexandra Arranja, & Luís F. Gouveia. (2013). Experimental design towards an optimal lipid nanosystem: A new opportunity for paclitaxel-based therapeutics. European Journal of Pharmaceutical Sciences. 49(2). 302–310. 16 indexed citations
15.
Silva, Joana M., Mafalda Videira, Rogério Gaspar, Véronique Préat, & Helena F. Florindo. (2013). Immune system targeting by biodegradable nanoparticles for cancer vaccines. Journal of Controlled Release. 168(2). 179–199. 189 indexed citations
16.
Videira, Mafalda, António J. Almeida, & Àngels Fabra. (2011). Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect. Nanomedicine Nanotechnology Biology and Medicine. 8(7). 1208–1215. 99 indexed citations
17.
Videira, Mafalda, et al.. (2009). Synthesis and structural studies of mixed-ligand rhenium(V) complexes anchored by tridentate pyrazole-based ligands. Inorganica Chimica Acta. 362(8). 2807–2813. 15 indexed citations
18.
Maria, Leonor, Mafalda Videira, Lurdes Gano, et al.. (2007). Rhenium and technetium tricarbonyl complexes anchored by pyrazole-based tripods: novel lead structures for the design of myocardial imaging agents. Dalton Transactions. 3010–3010. 53 indexed citations
19.
Vítor, Rute F., Isabel Correia, Mafalda Videira, et al.. (2007). Pyrazolyl–Diamine Ligands That Bear Anthracenyl Moieties and Their Rhenium(I) Tricarbonyl Complexes: Synthesis, Characterisation and DNA‐Binding Properties. ChemBioChem. 9(1). 131–142. 33 indexed citations
20.
Videira, Mafalda, Maria Filomena Botelho, Ana C. Santos, et al.. (2002). Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles. Journal of drug targeting. 10(8). 607–613. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sushilkumar Patil Breakdown of academic impact, for papers by Imran Vhora Breakdown of academic impact, for papers by Adam W. G. Alani Breakdown of academic impact, for papers by Hanh Thuy Nguyen Breakdown of academic impact, for papers by Sumio Chono Breakdown of academic impact, for papers by Dipesh Baradia Breakdown of academic impact, for papers by Jiasheng Tu Breakdown of academic impact, for papers by Mengchi Sun Breakdown of academic impact, for papers by Ping Tan Breakdown of academic impact, for papers by Raquel Petrilli
Rankless by CCL
2026